Saladax Biomedical Inc. of Bethlehem, a diagnostics company providing kits to test for drug-level adherence and dose management, said it has received approval to sell two of its products on the European market, an approval the company called a major opportunity.
Saladax Biomedical Inc. of Bethlehem, a diagnostics company providing kits to test for drug-level adherence and dose management, said it has received approval to sell two of its products on the European market, an approval the company called a major opportunity.Login
User ID / Email / Password is case sensitive
Don't have account? Subscribe
To inquire about group subscriptions or an enterprise site license for your organization, contact Tracy Bumba.
Get Essential Business News
1 Year Print & Digital
$99
1 Year Print +Digital + Data Joe (BOL)
$299
1 Year Digital Only
$99
Monthly Digital Only
$7.99
First time registering your paid subscription? Click here
Having trouble with login?
Please contact [email protected].
